Anne-vibeke V. Laenkholm
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Artificial Intelligence (AI)-Assisted Human Epidermal Growth Factor Receptor 2 (HER2) Scoring in Breast Cancer: Diagnostic Agreement and Understanding Discordance.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: March 04, 2026
Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: January 03, 2026
AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancer.
Journal: NPJ breast cancer
Published: October 24, 2025
Validation of a deep learning-based AI model for breast cancer risk stratification in postmenopausal ER+/HER2-breast cancer patients.
Journal: Breast (Edinburgh, Scotland)
Published: July 22, 2025
AI assessment of tumor-infiltrating lymphocytes on routine H&E-slides as a predictor of response to neoadjuvant therapy in breast cancer-a real-world study.
Journal: Virchows Archiv : an international journal of pathology
Published: June 24, 2025
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study.
Journal: Breast cancer research and treatment
Published: February 13, 2025
Effects of Supervised Exercise during Neoadjuvant Chemotherapy on Tumor Response in Patients with Breast Cancer (Neo-train): A Randomized Controlled Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 05, 2025
Multi-transcriptomics predicts clinical outcome in systemically untreated breast cancer patients with extensive follow-up.
Journal: Breast cancer research : BCR
Published: January 22, 2025
Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 04, 2024
Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer.
Journal: NPJ breast cancer
Published: September 06, 2024
Effect modification between HLA-F and CD56 markers reveals differences in survival for triple-negative breast cancer patients.
Journal: Human immunology
Published: August 07, 2024
Human Epidermal Growth Factor Receptor 2 Pan Tumor Indication for Trastuzumab Deruxtecan.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 05, 2024
Last Updated: 09/26/2026